Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2014 | 2 |
2015 | 2 |
2016 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Decreasing HepG2 Cytotoxicity by Lowering the Lipophilicity of Benzo[d]oxazolephosphinate Ester Utrophin Modulators.
ACS Med Chem Lett. 2020 Nov 4;11(12):2421-2427. doi: 10.1021/acsmedchemlett.0c00405. eCollection 2020 Dec 10.
ACS Med Chem Lett. 2020.
PMID: 33335663
Free PMC article.
An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-f] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases.
Chaikuad A, Diharce J, Schröder M, Foucourt A, Leblond B, Casagrande AS, Désiré L, Bonnet P, Knapp S, Besson T.
Chaikuad A, et al. Among authors: casagrande as.
J Med Chem. 2016 Nov 23;59(22):10315-10321. doi: 10.1021/acs.jmedchem.6b01083. Epub 2016 Nov 2.
J Med Chem. 2016.
PMID: 27766861
Item in Clipboard
DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3.
Thompson BJ, Bhansali R, Diebold L, Cook DE, Stolzenburg L, Casagrande AS, Besson T, Leblond B, Désiré L, Malinge S, Crispino JD.
Thompson BJ, et al. Among authors: casagrande as.
J Exp Med. 2015 Jun 1;212(6):953-70. doi: 10.1084/jem.20150002. Epub 2015 May 25.
J Exp Med. 2015.
PMID: 26008897
Free PMC article.
Item in Clipboard
A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro.
Coutadeur S, Benyamine H, Delalonde L, de Oliveira C, Leblond B, Foucourt A, Besson T, Casagrande AS, Taverne T, Girard A, Pando MP, Désiré L.
Coutadeur S, et al. Among authors: casagrande as.
J Neurochem. 2015 May;133(3):440-51. doi: 10.1111/jnc.13018. Epub 2015 Jan 26.
J Neurochem. 2015.
PMID: 25556849
Free article.
Item in Clipboard
Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part I.
Foucourt A, Hédou D, Dubouilh-Benard C, Désiré L, Casagrande AS, Leblond B, Loäec N, Meijer L, Besson T.
Foucourt A, et al. Among authors: casagrande as.
Molecules. 2014 Sep 29;19(10):15546-71. doi: 10.3390/molecules191015546.
Molecules. 2014.
PMID: 25268714
Free PMC article.
Item in Clipboard
Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part II.
Foucourt A, Hédou D, Dubouilh-Benard C, Girard A, Taverne T, Casagrande AS, Désiré L, Leblond B, Besson T.
Foucourt A, et al. Among authors: casagrande as.
Molecules. 2014 Sep 26;19(10):15411-39. doi: 10.3390/molecules191015411.
Molecules. 2014.
PMID: 25264830
Free PMC article.
Item in Clipboard
Assessment of the novel tubulin-binding agent EHT 6706 in combination with ionizing radiation or chemotherapy.
Clémenson C, Chargari C, Désiré L, Casagrande AS, Bourhis J, Deutsch E.
Clémenson C, et al. Among authors: casagrande as.
Invest New Drugs. 2012 Dec;30(6):2173-86. doi: 10.1007/s10637-011-9785-3. Epub 2012 Jan 14.
Invest New Drugs. 2012.
PMID: 22246215
Item in Clipboard
Cite
Cite